Since 2022, four GLP-1 drugs, including those indicated for weight loss, have been on FDA’s drug shortage list due to extraordinarily high patient demand. The shortage has, in turn, resulted in ...
Especially in women’s health, this former regulatory gray area could help patients who have waited too long for FDA-approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results